Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

PharmaSynth

PharmaSynth
2008 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of contract manufacturing services. The company offers manufacturing of recombinant proteins and vaccines, microbial products, fermentation optimization, downstream processing and related services in Australia.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Commercial Services
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Acquirer
Luina Biotechnology
Primary Office
  • 2806 Ipswich Road
  • Darra, Queensland 4076
  • Australia

+61 (07) 0000 0000

PharmaSynth Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore PharmaSynth‘s full profile, request access.

Request full access to PitchBook

PharmaSynth Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore PharmaSynth‘s full profile, request access.

Request full access to PitchBook

PharmaSynth Executive Team (1)

Name Title Board
Seat
Contact
Info
Leslie Tillack Chief Executive Officer & Director